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related ambulatory care visits over a 6 year period. Although all
age groups demonstrated an increase in stroke-related visit rates
during the study period, the 55–64 year age group had the most
signiﬁcant rise. Among persons aged 55–64 years, stroke-related
visit rates increased from 9.1/1000 persons to 39.1/1000 persons
(P Trend=<0.0001), resulting in a 428% rise. After adjustment,
greater odds of stroke visits were found in persons 55 years
(55–64 years OR = 3.4, 95%CI: 2.3–5.0; 65–74 years OR = 4.1,
95%CI: 2.7–6.2; 75 years OR = 5.4, 95%CI: 3.6–8.2) (age
45–54 referent), blacks (OR = 1.4, 95%CI: 1.0–2.0), men
(OR = 1.5, 95%CI: 1.2–1.9), or persons in the South (OR = 1.6,
95%CI: 1.2–2.1). CONCLUSION: From 2000 to 2005, stroke-
related ambulatory visits increased signiﬁcantly in the United
States, particularly among the near-elderly, Southern residents,
and blacks. These age, regional, and racial disparities in outpatient
stroke utilization are not explained by stroke risk factor preva-
lence. Health care resource allocation needs to target these high-
risk groups.
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OBJECTIVES: Health care utilization in Burkina Faso is far
below the average level in OECD countries (0.15 and eight
contacts per capita and year respectively). Worse still, there is a
pronounced income elasticity of demand. Hence, much of the
potential beneﬁt of effective drugs remains elusive for most of the
sick poor. This paper reports on the enrollment of the poorest
quintile in CBI and the change in health care utilization of the
insured households. Further more, the effect of a targeted subsidy
on enrollment of the poorest 5th of household was assessed.
METHODS: Community-based insurance has been offered to a
district in Burkina Faso, comprising 74,000 people who lived in
53 villages and the district capital of Nouna since 2004. Com-
munity self assessment of poverty was used in 2007 to identify
the poorest quintile of households who were subsequently
offered insurance at half the usual premium rate. RESULTS:
Overall enrollment in health insurance was 5.2% in 2006 and
8.3% in 2007. However, only 1.1% of the poorest quintile of
household chose to enroll. In 2007, with the targeted subsidy on
enrollment of poorest households, this rate reached 11.1%. Once
enrolled, households increased their utilization of health care
substantially (from 0.15 to 0.64 contacts per capita and year).
This increase in utilization given enrollment held also for the
poorest quintile. CONCLUSION: The authors discuss the cova-
riates inﬂuencing household decisions to enroll and to use health
care subsequently. They stress the need to enhance the access of
the poor to drugs and health care in general through the com-
bined effect of community-based insurance and targeted subsi-
dies to the poor.
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OBJECTIVE: To explore the impact of the 2007 southern Cali-
fornia wildﬁres on prescription medication access. METHODS:
CVS Caremark members living within San Diego, LA/Ventura,
Orange, and San Bernardino counties were split into Wildﬁre
(n = 83,479) and non-Wildﬁre (n = 145,325) cohorts using zip
codes with documented wildﬁre activity between October 20 and
November 9, 2007. Weekly pharmacy claims prevalence rates
(prevalence) between July 21, and December 8, 2007 (providing
13 pre-, 3 concurrent, and 4 post-wildﬁre weeks) were derived;
calculated as the number of individuals with paid claim(s)
divided by all eligible individuals. Cohort-speciﬁc prevalence
rates were derived for: Analgesics (GPI 64 to 66), anxiolytics
(57), antidepressants (58), antihyperlipidemics (39), antihyper-
tensives (36), beta-blockers (33), hypnotics (60), migraine (67),
respiratory (41 to 45), anti-ulcer (49), and across all classes.
Weekly deviations from cohort- and class-speciﬁc 20-week mean
prevalence were expressed as percentages. RESULTS: Mean
weekly prevalence was 75/1000 for Wildﬁre and 73/1000 for
non-Wildﬁre cohorts. Overall prevalence was below the mean
for both cohorts during the ﬁrst week of the wildﬁre period
(Wildﬁre: -12.9%, non-Wildﬁre: -4.8%); with the Wildﬁre
cohort experiencing decreases approximately four-fold greater
than the non-Wildﬁre cohort in antidepressants, antihyperlipi-
demics, antihypertensives, two-fold greater in anxiolytics, and
similar for all other classes except for the respiratory class, the
only classwith a prevalence increase relative to themean (Wildﬁre:
10.1%, non-Wildﬁre: 30.8%). During the second week, preva-
lence increased above the mean in all classes among the Wildﬁre
cohort (4% higher overall) but was mixed for the non-Wildﬁre
cohort (0.9% lower overall). Differences for almost every week
before and after the ﬁres were about equal. CONCLUSION:
Natural disasters can have a signiﬁcant affect on access to needed
medications. The wildﬁres in California decreased overall and
class-speciﬁc medication acquisition during the ﬁrst week except
for respiratory medications. The pharmacy system accommo-
dated these localized emergencies well.
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OBJECTIVE: The efﬁcacy of angiotensin converting-enzyme
inhibitors (ACEI), angiotensin II receptor blockers (ARB), beta-
blockers (BB), aldosterone antagonists (AA), digoxin (DG), and
diuretics (DU) in reducing morbidity and mortality among
persons with heart failure (HF) has been well established in
clinical trials. Using the 2002 Medicare Current Beneﬁciary
Survey, we determined utilization of these drugs in the real-world
setting among community-dwelling older adults with HF.
METHODS: Community-dwelling, non-hospice beneﬁciaries
>65 years of age with a diagnosis code for HF (428.xx) were
included. Medication use was determined by beneﬁciary self-
report, documentation of prescription ﬁlls, and computer-
assisted personal interviews. Diagnosis codes were used to
identify beneﬁciaries without medical contraindications for each
drug, who were eligible to receive them. We further classiﬁed
beneﬁciaries into groups based on concomitant use of more than
one drug: ACEI or ARB and BB (group 1); ACEI or ARB, BB, and
AA (group 2); and ACEI or ARB, BB, AA, DG, and DU (group
3). RESULTS: We estimated that 1038, 590, 821, 1059, and 926
survey respondents were eligible to use an ACEI or ARB, BB, AA,
DG, or DU, respectively. Among those eligible, 55.9%, 44.1%,
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